查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
關節痛注射的全球市場-成長，未來展望，競爭分析(2022年～2030年)
市場調查報告書
商品編碼
1149161

關節痛注射的全球市場-成長，未來展望，競爭分析(2022年～2030年)

Joint Pain Injections Market - Growth, Future Prospects and Competitive Analysis, 2022 - 2030
出版日期: | 出版商: Acute Market Reports | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格

全球關節痛注射的市場規模在2022年～2030年的預測期間內預計將以9.7％的年複合成長率增長。腱鞘炎的劇增，行動電話等電子設備的普及，肥胖的增加，關節內粘稠補充療法的增加，推動了關節痛注射市場的成長。

本報告提供全球關節痛注射市場相關調查分析，提供商務展望，市場動態，市場分析，企業簡介等系統性資訊。

目錄

第1章 序文

  • 報告的說明
    • 報告的目的
    • 對象者
    • 主要的產品
  • 市場區隔
  • 調查手法
    • 階段Ⅰ-2次調查
    • 階段Ⅱ-1次調查
    • 階段Ⅲ-專家的審查
    • 假設
    • 所採用的方法

第2章 摘要整理

  • 市場概述:全球關節痛注射市場
  • 全球關節痛注射市場(100萬美元)(2021年):注射
  • 全球關節痛注射市場(100萬美元)(2021年):各關節
  • 全球關節痛注射市場(100萬美元):各地區
  • COVID-19影響
  • 富有魅力的投資提案(2021年):各地區
  • 競爭分析
    • 主要的關節痛注射市場供應商的市場定位
    • 關節痛注射市場供應商僱用的策略
    • 主要的產業策略

第3章 關節痛注射市場:商務展望和市場動態

  • 簡介
  • 全球關節痛注射的市場金額(100萬美元)(2020年～2030年)
  • 市場動態
    • 推動市場要素
    • 阻礙市場要素
    • 主要課題
    • 主要的機會
  • 促進因素與阻礙因素的影響分析
  • Seesaw分析
  • 波特的五力分析
    • 供應商的力量
    • 買主的力量
    • 替代品的威脅
    • 新加入廠商業者的威脅
    • 競爭企業間的敵對關係
  • PESTEL分析
    • 政治
    • 經濟
    • 技術性
    • 法律
    • 社會

第4章 關節痛注射市場，美金(100萬)(2020年～2030年):注射

  • 市場概要
  • 成長和收益分析:2021年和2030年的比較
  • 市場區隔
    • 玻尿酸注射
    • 皮質類固醇注射
    • 其他

第5章 關節痛注射市場，美金(100萬)(2020年～2030年):各關節

  • 市場概要
  • 成長和收益分析:2021年和2030年的比較
  • 市場區隔
    • 髖關節
    • 膝·腳踝
    • 肩膀·肘
    • 脊椎椎間關節
    • 其他

第6章 北美的關節痛注射市場，美金(100萬)(2020年～2030年)

第7章 英國及歐洲聯盟的關節痛注射市場，美金(100萬)(2020年～2030年)

第8章 亞太地區的關節痛注射市場，美金(100萬)(2020年～2030年)

第9章 南美的關節痛注射市場，美金(100萬)(2020年～2030年)

第10章 中東及非洲的關節痛注射市場，美金(100萬)(2020年～2030年)

第11章 企業簡介

  • Allergan, Plc.
  • Anika Therapeutics, Inc.
  • Bioventus LLC
  • Chugai Pharmaceutical Co., Ltd.
  • Flexion Therapeutics, Inc.
  • Ferring B.V.
  • Pfizer, Inc.
  • Sanofi S.A.
  • SEIKAGAKU Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: 138672-08-22

Industry Outlook

The joint pain injections market is set to exhibiting outstanding growth at a compound annual growth rate (CAGR) of 9.7% during the forecast period from 2022 to 2030. As per the latest research citing brought forward by Global Burden of Disease Study the burden associated with musculoskeletal disorders is approximately 6.8% of DALYs worldwide.

Excellent lubrication and shock absorbing properties similar to synovial fluid has led to the increasing demand for hyaluronic acid injections for joint pains

Hyaluronic acid injection is reigning the injections segment for joint pain injections market. The human joints are similar to gears subjected to constant wear and tear, hyaluronic acid possess excellent lubrication and shock absorbing properties similar to synovial fluid thereby reducing joint stiffness and tenderness. Corticosteroid injections are used as an adjuvant medication in joint pain owing to its anti-inflammatory properties and ability to provide short term relief in joint sprains experienced by athletes and industrial workers.

Significant rise in tenosynovitis and prolonged physical activity drive the knee & ankle joint market growth

Currently knee & ankle joints are dominating the joint segment for joint pain injections market. The major factors associated with its market growth are significant rise in tenosynovitis and prolonged physical activity. Increasing competition among athletes and rampant growth of production and manufacturing segment further bolster the knee & ankle joints market growth. Shoulder & elbow joints are anticipated to register impressive growth in the near future owing to increasing utilization of electronic gadgets such as laptops, personal computer and mobile phones among general population. Rising prevalence of rotator cuff injury further consolidate the shoulder & elbow joints market growth.

Rising prevalence of obesity and high acceptance of viscosupplementation drive the market growth in North America

North America with a share of 34% is leading the regional segment for joint pain injections market. The chief attributes responsible for its dominance are rising prevalence of obesity and high acceptance of viscosupplementation. Domicile of key players such as Sanofi S.A., Allergan, Plc., Pfizer, Inc. etc. provide necessary impetus to the joint pain injections market growth in North America region. Europe is in the second position with a share of 28% owing to the rising prevalence of osteoarthritis in geriatric population. Affordable reimbursement scenario associated with joint pain injections propel the market growth in European region. Asia Pacific holds 20% market share and will grow at a faster pace during the forecast period on account of significant rise in musculoskeletal disorders and increasing cases of accidents and physical trauma.

Pharmaceutical companies pioneering in the joint pain injections market are: Allergan, Plc., Anika Therapeutics, Inc., Bioventus LLC., Chugai Pharmaceutical Co., Ltd., Flexion Therapeutics, Inc., Ferring B.V., Pfizer, Inc., Sanofi S.A., SEIKAGAKU Corporation and Zimmer Biomet Holdings, Inc.

Historical & Forecast Period

This study report represents analysis of each segment from 2020 to 2030 considering 2021 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2030.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Joint Pain Injections market are as follows:

  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Joint Pain Injections market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Injection

  • Hyaluronic Acid Injections
  • Corticosteroid Injections
  • Others

Joint

  • Hip Joint
  • Knee & Ankle
  • Shoulder & Elbow
  • Facet Joints of the Spine
  • Others

Region Segment (2020-2030; US$ Million)

  • North America
    • U.S.
    • Canada
    • Rest of North America
  • UK and European Union
    • UK
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

Global Impact of COVID-19 Segment (2020-2021; US$ Million )

  • Pre COVID-19 situation
  • Post COVID-19 situation

Key questions answered in this report:

  • What are the key micro and macro environmental factors that are impacting the growth of Joint Pain Injections market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2030.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Joint Pain Injections market?
  • Which is the largest regional market for Joint Pain Injections market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Joint Pain Injections market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Joint Pain Injections market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Joint Pain Injections Market
  • 2.2. Global Joint Pain Injections Market, By Injection, 2021 (US$ Million)
  • 2.3. Global Joint Pain Injections Market, By Joint, 2021 (US$ Million)
  • 2.4. Global Joint Pain Injections Market, By Geography, 2021 (US$ Million)
  • 2.5. Impact of Covid 19
  • 2.6. Attractive Investment Proposition by Geography, 2021
  • 2.7. Competitive Analysis
    • 2.7.1. Market Positioning of Key Joint Pain Injections Market Vendors
    • 2.7.2. Strategies Adopted by Joint Pain Injections Market Vendors
    • 2.7.3. Key Industry Strategies

3. Joint Pain Injections Market: Business Outlook & Market Dynamics

  • 3.1. Introduction
  • 3.2. Global Joint Pain Injections Market Value, 2020 - 2030, (US$ Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers
    • 3.3.2. Market Restraints
    • 3.3.3. Key Challenges
    • 3.3.4. Key Opportunities
  • 3.4. Impact Analysis of Drivers and Restraints
  • 3.5. See-Saw Analysis
  • 3.6. Porter's Five Force Model
    • 3.6.1. Supplier Power
    • 3.6.2. Buyer Power
    • 3.6.3. Threat Of Substitutes
    • 3.6.4. Threat Of New Entrants
    • 3.6.5. Competitive Rivalry
  • 3.7. PESTEL Analysis
    • 3.7.1. Political Landscape
    • 3.7.2. Economic Landscape
    • 3.7.3. Technology Landscape
    • 3.7.4. Legal Landscape
    • 3.7.5. Social Landscape

4. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)

  • 4.1. Market Overview
  • 4.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 4.3. Market Segmentation
    • 4.3.1. Hyaluronic Acid Injections
    • 4.3.2. Corticosteroid Injections
    • 4.3.3. Others

5. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2021 Versus 2030
  • 5.3. Market Segmentation
    • 5.3.1. Hip Joint
    • 5.3.2. Knee & Ankle
    • 5.3.3. Shoulder & Elbow
    • 5.3.4. Facet Joints of the Spine
    • 5.3.5. Others

6. North America Joint Pain Injections Market, 2020-2030, USD (Million)

  • 6.1. Market Overview
  • 6.2. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
  • 6.3. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
  • 6.4.Joint Pain Injections Market: By Region, 2020-2030, USD (Million)
    • 6.4.1.North America
      • 6.4.1.1. U.S.
      • 6.4.1.2. Canada
      • 6.4.1.3. Rest of North America

7. UK and European Union Joint Pain Injections Market, 2020-2030, USD (Million)

  • 7.1. Market Overview
  • 7.2. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
  • 7.3. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
  • 7.4.Joint Pain Injections Market: By Region, 2020-2030, USD (Million)
    • 7.4.1.UK and European Union
      • 7.4.1.1. UK
      • 7.4.1.2. Germany
      • 7.4.1.3. Spain
      • 7.4.1.4. Italy
      • 7.4.1.5. France
      • 7.4.1.6. Rest of Europe

8. Asia Pacific Joint Pain Injections Market, 2020-2030, USD (Million)

  • 8.1. Market Overview
  • 8.2. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
  • 8.3. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
  • 8.4.Joint Pain Injections Market: By Region, 2020-2030, USD (Million)
    • 8.4.1.Asia Pacific
      • 8.4.1.1. China
      • 8.4.1.2. Japan
      • 8.4.1.3. India
      • 8.4.1.4. Australia
      • 8.4.1.5. South Korea
      • 8.4.1.6. Rest of Asia Pacific

9. Latin America Joint Pain Injections Market, 2020-2030, USD (Million)

  • 9.1. Market Overview
  • 9.2. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
  • 9.3. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
  • 9.4.Joint Pain Injections Market: By Region, 2020-2030, USD (Million)
    • 9.4.1.Latin America
      • 9.4.1.1. Brazil
      • 9.4.1.2. Mexico
      • 9.4.1.3. Rest of Latin America

10. Middle East and Africa Joint Pain Injections Market, 2020-2030, USD (Million)

  • 10.1. Market Overview
  • 10.2. Joint Pain Injections Market: By Injection, 2020-2030, USD (Million)
  • 10.3. Joint Pain Injections Market: By Joint, 2020-2030, USD (Million)
  • 10.4.Joint Pain Injections Market: By Region, 2020-2030, USD (Million)
    • 10.4.1.Middle East and Africa
      • 10.4.1.1. GCC
      • 10.4.1.2. Africa
      • 10.4.1.3. Rest of Middle East and Africa

11. Company Profile

  • 11.1. Allergan, Plc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Portfolio
    • 11.1.4. Strategic Initiatives
  • 11.2. Anika Therapeutics, Inc.
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Portfolio
    • 11.2.4. Strategic Initiatives
  • 11.3. Bioventus LLC
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Portfolio
    • 11.3.4. Strategic Initiatives
  • 11.4. Chugai Pharmaceutical Co., Ltd.
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Portfolio
    • 11.4.4. Strategic Initiatives
  • 11.5. Flexion Therapeutics, Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Portfolio
    • 11.5.4. Strategic Initiatives
  • 11.6. Ferring B.V.
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Portfolio
    • 11.6.4. Strategic Initiatives
  • 11.7. Pfizer, Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Portfolio
    • 11.7.4. Strategic Initiatives
  • 11.8. Sanofi S.A.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Portfolio
    • 11.8.4. Strategic Initiatives
  • 11.9. SEIKAGAKU Corporation
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Portfolio
    • 11.9.4. Strategic Initiatives
  • 11.10. Zimmer Biomet Holdings, Inc.
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Portfolio
    • 11.10.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
  • TABLE 2 Global Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
  • TABLE 3 North America Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
  • TABLE 4 North America Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
  • TABLE 5 UK and European Union Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
  • TABLE 6 UK and European Union Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
  • TABLE 7 Asia Pacific Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
  • TABLE 8 Asia Pacific Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
  • TABLE 9 Latin America Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
  • TABLE 10 Latin America Joint Pain Injections Market By Joint, 2020-2030, USD (Million)
  • TABLE 11 Middle East and Africa Joint Pain Injections Market By Injection, 2020-2030, USD (Million)
  • TABLE 12 Middle East and Africa Joint Pain Injections Market By Joint, 2020-2030, USD (Million)

List of Figures

  • FIG. 1 Global Joint Pain Injections Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Joint Pain Injections Market: Quality Assurance
  • FIG. 5 Global Joint Pain Injections Market, By Injection, 2021
  • FIG. 6 Global Joint Pain Injections Market, By Joint, 2021
  • FIG. 7 Global Joint Pain Injections Market, By Geography, 2021
  • FIG. 8 Global Joint Pain Injections Market, By Injection, 2021 Vs 2030, %
  • FIG. 9 Global Joint Pain Injections Market, By Joint, 2021 Vs 2030, %
  • FIG. 10 U.S. Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 11 Canada Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 12 Rest of North America Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 13 UK Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 14 Germany Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 15 Spain Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 16 Italy Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 17 France Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 18 Rest of Europe Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 19 China Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 20 Japan Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 21 India Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 22 Australia Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 23 South Korea Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 24 Rest of Asia Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 25 Brazil Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 26 Mexico Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 27 Rest of Latin America Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 28 GCC Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 29 Africa Joint Pain Injections Market (US$ Million), 2020 - 2030
  • FIG. 30 Rest of Middle East and Africa Joint Pain Injections Market (US$ Million), 2020 - 2030